[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:sox11-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"SOX11 Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05976763","Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma",[11],"Phase 3","RECRUITING","2026-08-26T02:17:07.954622Z","2026-07-19T19:36:05.124289Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05861050","Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma",[19],"Phase 1\u002FPhase 2","2026-08-26T02:19:25.538428Z","2026-05-05T02:43:28.958425Z"]